ADPT logo
ADPT NASDAQ US

Adaptive Biotechnologies Corporation - Common Stock

Healthcare · Life Sciences Tools & Services Website · IPO Jun 2019
$14.81
▲ +$0.38 (+2.63%)
Vol 1.6M
7
Quality Score
fail
Mkt Cap
$2.5B
ROE
-41.1%
Margin
-31.6%
D/E
64.49
Beta
2.18
52W
$6–$21

Wall Street Consensus

14 analysts · Apr 2026
5
Strong Buy
7
Buy
2
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

BRKR
Bruker Corp
$7.2B
SHC
Sotera Health Co
P/E 90.4
$5.0B
TXG
10X Genomics Inc
$2.1B
AZTA
Azenta Inc
$1.5B
BLFS
BioLife Solutions Inc
$1.2B
FTRE
Fortrea Holdings Inc
$1.6B
PSNL
Personalis Inc
$706.9M
CTKB
Cytek Biosciences Inc
$645.7M

Earnings

Beat rate: 100.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.18 $-0.09 +$0.09
Sep 2025 $-0.15 $0.06 +$0.21
Jun 2025 $-0.24 $-0.17 +$0.07
Mar 2025 $-0.30 $-0.20 +$0.10

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Revenue — $47.5M $52.4M $58.9M $94.0M $71.7M
Net Income — -$33.7M -$29.9M -$25.6M $9.5M -$13.6M

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -61.0% -60.9% -60.9% -60.9% -41.1% -41.1%
P/E (TTM) — — — — — —
Net Margin -43.5% -59.1% -59.1% -59.1% -31.6% -31.6%
Gross Margin 69.4% 66.0% 66.0% 66.0% 71.8% 71.8%
D/E Ratio 74.32 74.32 74.32 74.32 64.49 64.49
Current Ratio 2.84 2.84 2.84 2.84 3.38 3.38

Key Ratios

ROA (TTM)
-15.7%
P/S (TTM)
9.81
P/B
4.4
EPS (TTM)
$-0.54
CF/Share
$-1.21
Rev Growth 3Y
+5.1%
52W High
$20.76
52W Low
$5.91
$5.91 52-Week Range $20.76

Financial Health

Free Cash Flow
$1.4M
Net Debt
$8.7M
Cash
$70.5M
Total Debt
$79.1M
As of Dec 31, 2025

How does ADPT compare to Life Sciences Tools & Services peers?

Peer group: Small-cap Life Sciences Tools & Services ($300M+) · 25 companies

ADPT ABCL AZTA BLFS BRKR

ADPT valuation vs Life Sciences Tools & Services peers

P/E ratio
—
▼ 0% below peers (32.5)
vs Peers
vs Industry
Fair value
P/S ratio
9.8
▲ 157% above peers (3.8)
vs Peers
vs Industry
Overvalued
P/B ratio
4.4
▲ 17% above peers (3.7)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.5%)
vs Peers
vs Industry
Low yield

ADPT profitability vs Life Sciences Tools & Services peers

ROE
-41.1%
▼ 1157% below peers (-3.3%)
vs Peers
vs Industry
Weak
Net margin
-31.6%
▼ 237% below peers (-9.4%)
vs Peers
vs Industry
Weak
Gross margin
71.8%
▲ 50% above peers (48.0%)
vs Peers
vs Industry
Top tier
ROA
-15.7%
▼ 503% below peers (-2.6%)
vs Peers
vs Industry
Weak

ADPT financial health vs Life Sciences Tools & Services peers

D/E ratio
64.5
▲ 77% above peers (36.5)
vs Peers
vs Industry
Above avg
Current ratio
3.4
▼ 0% below peers (3.4)
vs Peers
vs Industry
In line
Beta
2.2
▲ 54% above peers (1.4)
vs Peers
vs Industry
More volatile

ADPT fundamentals radar

ADPT Peer median Industry

ADPT profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ADPT vs peers: key metrics

Insider Activity

Neutral
Buys
0
Sells
0
RUBINSTEIN JULIAN
President · Mar 23
44166 shs
RUBINSTEIN JULIAN
President · Mar 23
57180 shs
RUBINSTEIN JULIAN
President · Mar 18
44166 shs
RUBINSTEIN JULIAN
President · Mar 18
57180 shs
RUBINSTEIN JULIAN
President · Mar 13
44166 shs
RUBINSTEIN JULIAN
President · Mar 13
179703 shs
LO FRANCIS
Officer · Mar 11
30593 shs
BOBULSKY SUSAN
Officer · Mar 11
41338 shs
ROBINS HARLAN S.
Officer · Mar 11
470266 shs
GRIFFIN MICHELLE RENEE
Director · Mar 11
15394 shs
Last 90 days

Top Holders

Top 5: 40.96%
Viking Global Investors, L.…
19.48%
$372.2M
Blackrock Inc.
8.66%
$165.5M
Vanguard Group Inc
7.33%
$140.0M
Price (T.Rowe) Associates I…
2.85%
$54.4M
Westfield Capital Managemen…
2.64%
$50.4M
As of Dec 31, 2025

Latest News

No related news yet